Abstract
Worldwide, cardiovascular disease (CVD) is estimated to be the leading cause of death and loss of disability-adjusted life years. Although age-adjusted cardiovascular death rates have declined in several developed countries in past decades, rates of cardiovascular disease have risen greatly in low-income and middle-income countries [1]. CVD is now the leading cause of death in all developing regions, with the exception of sub-Saharan Africa [1]. It causes twice as many deaths as HIV, malaria, and tuberculosis combined. Furthermore, due to the increasing prevalence of risk factors and lack of appropriate preventive measures, a relatively younger population is affected by CVD in these countries [2]. This leads to the loss of many potential years of productive life and places a huge economic burden on these countries. Hence, efforts to produce even modest reductions in age-specific disease rates could have a very large economic impact.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gaziano TA, Bitton A, et al. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72–115.
Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007;26(1):13–24.
Kannel WB, Dawber TR, et al. Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50.
American Heart Association. Heart Disease and Stroke Statistics—2004 Update. http://www.americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf. Accessed 1 Dec 2004.
Yusuf S, Hawken S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364(9438):937–52.
Joshi R, Jan S, Wu Y, et al. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol. 2008;52(23):1817–25.
Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011;32:5–22.
Ford ES, Ajani UA, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356(23):2388–98.
Fortmann SP, Williams PT, et al. Effect of health education on dietary behavior: the Stanford Three Community Study. Am J Clin Nutr. 1981;34(10):2030–8.
Fortmann SP, Taylor CB, et al. Effect of community health education on plasma cholesterol levels and diet: the Stanford Five-City Project. Am J Epidemiol. 1993;137(10):1039–55.
Puska P, Nissinen A, et al. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health. 1985;6:147–93.
Barker DJ. Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health. 2012;126(3):185–9.
Forse T, Eriksson JG, et al. Mother’s weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ. 1997;315:837–40.
Fall CHD, Stein CE, et al. Size at birth, maternal weight, and type 2 diabetes in south India. Diabet Med. 1998;15:220e7.
Centers for Disease Control and Prevention (CDC). Prevalence of abnormal lipid levels among youths: United States, 1999–2006. MMWR Morb Mortal Wkly Rep. 2010;59:29–33.
Din-Dzietham R, Liu Y, et al. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116:1488–96.
Savoye M, Shaw M, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA. 2007;297:2697–704.
Foster GD, Linder B, et al. A school-based intervention for diabetes risk reduction. N Engl J Med. 2010;363:443–53.
Li S, Chen W, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290:2271–6.
McGill Jr HC, McMahan CA, et al. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation. 2001;103:1546–50.
Urbina EM, Kimball TR, et al. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. 2009;119:2913–9.
Juonala M, Magnussen CG, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122:2514–20.
Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. JAMA. 1995;273(18):1429–35.
Wiegman A, Hutten BA, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331–7.
Hollar D, Messiah SE, et al. Healthier options for public schoolchildren program improves weight and blood pressure in 6- to 13-year-olds. J Am Diet Assoc. 2010;110:261–7.
Lloyd-Jones DM, Leip EP, et al. Prediction of lifetime risk for cardio- vascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791–8.
Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547–53.
Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–43.
Shroufi A, Chowdhury R, et al. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health. 2013;13:285.
Teo KK, Ounpuu S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case–control study. Lancet. 2006;368(9536):647–58.
Weintraub WS, Daniels SR, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124(8):967–90.
Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006;368(9536):679–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Barekatain, A., Weiss, S., Weintraub, W.S. (2015). Value of Primordial and Primary Prevention for Cardiovascular Diseases: A Global Perspective. In: Andrade, J., Pinto, F., Arnett, D. (eds) Prevention of Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-22357-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-22357-5_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22356-8
Online ISBN: 978-3-319-22357-5
eBook Packages: MedicineMedicine (R0)